Alongside other industry leaders, our CEO Prof. Ronald Li shared at #Healthtech O2O Summit of @StartmeupHK Festival 2019 on how he had led Novoheart to become a listed global technology company devoted to revolutionizing #DrugDiscovery. Read more on MIMS: goo.gl/9vL6SQ
CEO and Founder Prof. Ronald Li shares his personal journey as a #technopreneur growing Novoheart into a global #stemcell #biotech company, in this latest piece by MinuteHack. Read more: bit.ly/2E4yIE7
#HeartMonth #drugdiscovery #bioengineering #regenerativemedicine
The Japanese government has just approved the use of #iPS cells in clinical trials as treatment for spinal cord injuries, in addition to trials for heart failure and Parkinson’s, setting another precedent for global regenerative medicine development. s.nikkei.com/2GyXFtB
It was a pleasure hosting visitors from AstraZeneca at our Hong Kong facilities last week: Prof. Ronald Li, CEO and Founder, and Dr. Bernard Fermini, Chief R&D Officer introduced to the guests our capabilities in revolutionizing #drugdiscovery using the MyHeart Platform.
Evidence of #HongKongPoliceTerrorism during #HongKongProtests throughout the past five months for the world to see and condemn. #反送中 #反送中デモ
youtu.be/irgVDTldHI8
THREAD:
Today - 3 May - is #WorldPressFreedomDay
I've written this message in my own hand and from my heart for #HongKongers and for #PressFreedom throughout the world.
#JournalismIsNotACrime #FreeJimmyLai